How Alberta Drug Plan Changes Could Affect Employee Benefit Costs in 2026

Beginning October 1, 2026, three changes could affect the cost of employer-sponsored drug plans in Alberta:

New payor-of-last-resort rules under Bill 11
Higher pharmacy dispensing fees
The introduction of lower-cost generic semaglutide

For small and mid-sized Alberta businesses, the cost impact will not necessarily move in one direction. Bill 11 and dispensing fee changes might place upward pressure on claims, while generic semaglutide could mean savings for plans that cover the medication.

How it plays out will depend on the employees covered, the medications they use and how the benefit plan is designed. That makes the months before renewal an important time to review claims data, understand the available cost-management options, and prepare employees for changes.

What Alberta Drug Plan Changes Are Coming in October 2026?

In October, Alberta employers will notice changes in both who pays for certain claims and what some prescription claims cost.

Bill 11 will change the coordination of benefits rules so that, in some cases, an employer-sponsored plan will need to pay before a government-sponsored plan. That could mean more eligible drug and health claims flowing through private plans.

At the same time, higher pharmacy dispensing fees may add some cost pressure, while lower-cost generic versions of semaglutide, the medication used in Ozempic, could offset part of that increase for some plans.

The important thing to know is that the impact will not look the same for every business. It will depend on things like plan design, recent claims, employee drug use, and whether the plan includes features such as generic pricing or dispensing fee caps.

If you’re already wondering how these changes may affect your benefit plan, book your free benefit plan review to get a clearer picture of potential cost pressures and options worth considering before renewal.

How Will Bill 11 Affect Private Employee Benefit Plans?

Bill 11 changes the order in which eligible health and drug claims are paid when someone has access to both private and government-sponsored coverage.

Under the new payor-of-last-resort approach, an eligible claim must generally be submitted to the private plan first. Government coverage would then apply after the available private coverage has been used.

For an employer, this means that claims previously paid partly or entirely through a government program will be applied to the company’s benefit plan.

What Is Changing With Alberta Pharmacy Dispensing Fees?

A dispensing fee is the professional fee a pharmacy charges when filling a prescription. It is separate from the cost of the medication itself.

Beginning October 1, 2026, the applicable dispensing fees outlined in the new Alberta framework will increase as follows:

Prescriptions for less than 84 days: dispensing fee increases from $12.15 to $12.35
Prescriptions for 84 days or more: dispensing fee increases from $12.15 to $13.50

How much of that increase is felt by the plan or the employee will depend partly on whether the benefit plan has a dispensing fee cap. If there is no cap, the additional eligible cost may flow through the plan and affect claims experience. If there is a cap, employees who use a pharmacy that charges more than the plan allows may pay more out of pocket.

That makes communication important, too. Even a relatively small change at the plan level can be more noticeable to employees who fill several prescriptions throughout the year.

Although the fee for an 84-day-or-longer prescription will be higher per fill, longer prescription supplies can mean fewer dispensing events over the course of a year. For example, an employee receiving a three-month supply of a maintenance medication may have four dispensing fees annually instead of 12 monthly fees.

Could Generic Semaglutide Reduce Drug Plan Costs?

Semaglutide is the active ingredient in medications including Ozempic and Wegovy. Ozempic is approved in Canada for the management of type 2 diabetes, while Wegovy is approved for chronic weight management. Ozempic has also been used off-label for weight loss, which explains why many people associate the medication with weight loss.

Generic semaglutide products began receiving Health Canada approval in spring 2026. For benefit plans with generic pricing or substitution policies, lower-cost generic options could reduce the amount paid for eligible semaglutide claims.

How much an employer benefits will depend on the medications being claimed and the rules of the individual plan, including generic pricing, which drugs are covered, and whether certain medications require approval before the plan will pay for them.

For some employers, these lower-cost options could offset some of the added cost from Bill 11 and higher dispensing fees. The actual impact will be different for every benefit plan.

What Is the Overall Effect on Benefit Plan Costs in Alberta?

When all three developments are considered together, Alberta Blue Cross projects a possible net change in drug spending ranging from a 1.90% decrease to a 4.55% increase. It expects most groups to experience a modest increase in claim costs.

The wide range is important.

There is no single percentage that every Alberta employer should add to its benefits budget. One business may benefit substantially from generic semaglutide pricing, while another may experience more claims because of the Bill 11 payment changes and receive little offsetting savings.

Employers will obtain a more useful estimate by looking at their own plan rather than relying only on industry averages. Every benefit plan will be affected differently.

Book a free, no-obligation plan review to get a clearer picture of what these changes could mean for your benefit plan costs.

What Should Alberta Employers Review Before Renewal?

Renewal should not be the first time these changes are discussed. Starting the conversation early and following a clear benefits plan renewal process gives employers more time to review claims, understand cost pressures, and consider their options before decisions are required.

For more ideas on balancing coverage and cost, read our guide to affordable employee benefits plans for small businesses.

Review the plan’s recent claims experience

Look at the types of claims affecting the plan, not just the total amount spent. Ask whether the organization has significant prescription drug use, recurring high-cost claims or growing use of medications such as Ozempic and Wegovy.

Past experience cannot predict every future claim, but it can help identify where the plan may be more exposed to the upcoming changes.

Examine the plan design

Employers should understand whether their plan includes:

A generic pricing or mandatory generic substitution policy
A dispensing fee cap
Requirements for certain medications to be approved before they are covered
Rules that determine which prescription drugs are covered
Limits on what the plan considers a reasonable cost for certain services or treatments
Programs designed to help manage prescription drug costs

Not every cost-control measure will be appropriate for every workforce. The objective is to find a balance between plan affordability, sustainable coverage and suitable access to medications.

Ask what drug-management options are available

Depending on the insurer and plan, there may be options to limit which drugs are covered, use lower-cost generic alternatives, require approval for certain medications, encourage use of preferred pharmacies, or set limits on dispensing fees.

Before adopting a change, employers should understand both its likely savings and its effect on employees.

A strategy that reduces the employer’s claims cost by shifting a large expense to plan members may create a different workplace problem. Cost management should be evaluated alongside employee experience and the purpose of the benefits program.

Prepare an employee communication plan

Employees may not be familiar with coordination of benefits, generic pricing or dispensing fee caps.

Clear employee benefits renewal communication can explain:

Why the amount paid by the plan or employee may change
How to coordinate private and government coverage
When a generic medication may be substituted
Whether longer prescription supplies are available and appropriate
Who to contact with questions about a claim

Employers should always avoid providing medical advice or directing employees to change medications. Treatment decisions belong between the employee and their healthcare provider. The employer’s role is to explain how the benefit plan works.

Start Preparing Before the Renewal Deadline

The October 1 changes arrive as many Alberta businesses are beginning or approaching benefit renewal discussions.

For small businesses, even modest claims increases matter. At the same time, reducing coverage without understanding the data can weaken a benefit program that helps attract and retain employees.

The best response is not to make assumptions. Rather, review the organization’s claims, plan provisions and available management strategies before decisions need to be made.

CG Hylton Inc. helps Alberta employers understand their employee benefit plans, evaluate cost-management options and prepare for renewal. A proactive review can provide a clearer picture of how these drug plan changes may affect the business and what adjustments, if any, should be considered. Book your free benefit plan review.

FAQs

When do Alberta’s new drug plan changes take effect?

The Bill 11 coordination changes and new pharmacy dispensing fees outlined in the plan briefing take effect on October 1, 2026. Generic semaglutide products began receiving Health Canada authorization earlier in 2026.

Will Bill 11 increase employer benefit costs?

It may. When a claim qualifies under both private and government-sponsored coverage, the private plan will generally be billed first. This could cause employer plans to pay claims that were previously paid through government programs.

Are pharmacy dispensing fees increasing in Alberta?

Yes. Effective October 1, 2026, the fee outlined for prescriptions covering less than 84 days rises from $12.15 to $12.35. The fee for supplies of 84 days or more rises to $13.50.

What should employers do before benefit renewal?

Employers should review their claims experience, dispensing fee provisions, generic pricing policy, which drugs are covered, and any approval requirements. They should also prepare clear employee communication before the changes begin affecting claims.

< Older Post